Sung Yong Ahn

Prof. Dr. Sung Yong Ahn

Department of Physiology, Ajou University School of Medicine, Suwon, Gyeonggi, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Anticancer Research
Verified
Journal Article
Open access
PDF file
Sung Yong AhnSung Yong Ahn
Sung Yong Ahn
Over the past few decades, longevity without disease has become an important topic worldwide. However, as life expectancy increases, the number of patients with cancer is also increasing. Tumor progression is related to interactions between tumor cells and mesenchymal stem cells (MSCs) in the tumor microenvironment. MSCs are multipotent stromal cells known to be present in a variety of locations in the body, including bones, cartilage, fat, muscles, and dental pulp. MSCs migrate toward inflamed areas during pathological immune responses. MSCs also migrate toward tumor stroma and participate in tumor progression. MSCs can contribute to tumor progression by interacting with tumor cells via paracrine signaling and differentiate into diverse cell types. This also enables MSCs to make direct contact with tumor cells in tumor stroma. Interactions between tumor cells and MSCs enhance tumorigenic and metastatic potential, in addition to stimulating epithelial to mesenchymal transition. Herein, we reviewed the research associated with the tumor-enhancing role of MSCs in tumor progression, from primary tumor growth to distant tumor metastasis.

14 October 2022 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
HKHee Ja Kim
Hee Ja Kim
KYKyungwon Yang
Kyungwon Yang
KKKiyoon Kim
Kiyoon Kim
YLYe‐Ji Lee
Ye‐Ji Lee
SLSieun Lee
Sieun Lee
JKJihee Lee Kang
Jihee Lee Kang
The interplay between apoptotic cancer cells and the tumor microenvironment modulates cancer progression and metastasis. Cancer-associated fibroblasts (CAFs) play a crucial role in promoting these events through paracrine communication. Here, we demonstrate that conditioned medium (CM) from lung CAFs exposed to apoptotic cancer cells suppresses TGF-β1-induced migration and invasion of cancer cells and CAFs. Direct exposure of CAFs to apoptotic 344SQ cells (ApoSQ) inhibited CAF migration and invasion and the expression of CAF activation markers. Enhanced secretion of Wnt‐induced signaling protein 1 (WISP-1) by CAFs exposed to ApoSQ was required for these antimigratory and anti-invasive effects. Pharmacological inhibition of Notch1 activation or siRNA-mediated Notch1 silencing prevented WISP-1 production by CAFs and reversed the antimigratory and anti-invasive effects. Enhanced expression of the Notch ligand delta-like protein 1 on the surface of ultraviolet-irradiated apoptotic lung cancer cells triggered Notch1-WISP-1 signaling. Phosphatidylserine receptor brain-specific angiogenesis inhibitor 1 (BAI1)-Rac1 signaling, which facilitated efferocytosis by CAFs, participated in crosstalk with Notch1 signaling for optimal production of WISP-1. In addition, a single injection of ApoSQ enhanced WISP-1 production, suppressed the expression of CAF activation markers in isolated Thy1+ CAFs, and inhibited lung metastasis in syngeneic immunocompetent mice via Notch1 signaling. Treatment with CM from CAFs exposed to ApoSQ suppressed tumor growth and lung metastasis, whereas treatment with WISP-1-immunodepleted CM from CAFs exposed to ApoSQ reversed the antitumorigenic and antimetastatic effects. Therefore, treatment with CM from CAFs exposed to apoptotic lung cancer cells could be therapeutically applied to suppress CAF activation, thereby preventing cancer progression and metastasis.

16 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
Sung Yong AhnSung Yong Ahn
Sung Yong Ahn
NKNam Hee Kim
Nam Hee Kim
KLKyungro Lee
Kyungro Lee
YCYong Hoon Cha
Yong Hoon Cha
JYJi Hye Yang
Ji Hye Yang
Jongin YOOKJongin YOOK
Jongin YOOK
Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction

16 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
Sung Yong AhnSung Yong Ahn
Sung Yong Ahn
JYJi Hye Yang
Ji Hye Yang
NKNam Hee Kim
Nam Hee Kim
KLKyungro Lee
Kyungro Lee
YCYong Hoon Cha
Yong Hoon Cha
Jongin YOOKJongin YOOK
Jongin YOOK
Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3 Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3

3 February 2020 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
Sung Yong AhnSung Yong Ahn
Sung Yong Ahn
YYong-Sun Maeng
Yong-Sun Maeng
YKYu Rim Kim
Yu Rim Kim
YCYoung Ho Choe
Young Ho Choe
HHHan Sung Hwang
Han Sung Hwang
YHYoung-Min Hyun
Young-Min Hyun
Background: Sepsis is a global inflammatory disease that causes death. It has been reported that mesenchymal stem cell (MSC) treatment can attenuate inflammatory and septic symptoms. In this study, we investigated how interactions between neutrophils and human umbilical cord blood (hUCB)-MSCs in the liver of septic mice are involved in mitigating sepsis that is mediated by MSCs. Accordingly, we aimed to determine whether hUCB-MSC application could be an appropriate treatment for sepsis. Methods: To induce septic condition, lipopolysaccharide (LPS) was intraperitoneally (i.p.) injected into mice 24 h after the intravenous (i.v.) injection of saline or hUCB-MSCs. To determine the effect of hUCB-MSCs on the immune response during sepsis, histologic analysis, immunoassays, and two-photon intravital imaging were performed 6 h post-LPS injection. For the survival study, mice were monitored for 6 days after LPS injection. Results: The injection (i.v.) of hUCB-MSCs alleviated the severity of LPS-induced sepsis by increasing IL-10 levels (p < 0.001) and decreasing mortality (p < 0.05) in septic mice. In addition, this significantly reduced the recruitment of neutrophils (p < 0.001) to the liver. In hUCB-MSC-treated condition, we also observed several distinct patterns of dynamic interactions between neutrophils and hUCB-MSCs in the inflamed mouse liver, as well as vigorous interactions between hepatic stellate cells (HSCs or ito cells) and hUCB-MSCs. Interestingly, hUCB-MSCs that originated from humans were not recognized as foreign in the mouse body and consequently did not cause graft rejection. Conclusions: These distinct interaction patterns between innate immune cells and hUCB-MSCs demonstrated that hUCB-MSCs have beneficial effects against LPS-induced sepsis through associations with neutrophils. In addition, the immunomodulatory properties of hUCB-MSCs might enable immune evasion in the host. Taken together, our results suggest the prospects of hUCB-MSCs as a therapeutic tool to inhibit inflammation and alleviate pathological immune responses such as sepsis.

1 September 2016 in Archives of Oral Biology
Verified
Journal Article
Closed access
YHYoung Sun Hwang
Young Sun Hwang
Sung Yong AhnSung Yong Ahn
Sung Yong Ahn
SMSook Moon
Sook Moon
ZZZhenlong Zheng
Zhenlong Zheng
ICIn-Ho Cha
In-Ho Cha
XZXianglan Zhang
Xianglan Zhang